Literature DB >> 22021498

CT features of peripheral pulmonary carcinoid tumors.

Quinn Colin Meisinger1, Jeffrey S Klein, Kelly J Butnor, George Gentchos, Bruce J Leavitt.   

Abstract

OBJECTIVE: Pulmonary carcinoid tumors are low-grade malignant neoplasms thought to arise primarily within the central airways in 85% of cases. The CT features of pulmonary carcinoid tumors that arise as solitary pulmonary nodules (SPNs) have not been well elucidated. We reviewed our experience with primary pulmonary carcinoid tumors to determine the distribution of lesions within the lung at diagnosis and to identify CT features that might aid in distinguishing these neoplasms from benign pulmonary nodules.
MATERIALS AND METHODS: CT scans, if available, of all patients with a primary pulmonary carcinoid tumor diagnosed by biopsy or surgical resection over the previous 15 years were reviewed. The CT scans were reviewed for the following features: lesion location; order of bronchus involved; lesion size, contour, and density; contrast enhancement; and the presence of peripheral atelectasis, hyperlucency, and bronchiectasis. We defined central lesions as those involved with a segmental or larger bronchus. Subsegmental bronchial involvement and tumors surrounded by lung parenchyma without direct airway involvement were defined as peripheral lesions. The final pathologic diagnosis for all cases was confirmed by review of cytologic or histologic specimens.
RESULTS: Twenty-eight carcinoid tumors were identified in 28 patients: 24 typical carcinoids and four atypical carcinoids. The study group was composed of 23 females and five males with a mean age of 52.4 years (range, 14-83 years). Twelve of the 28 lesions (43%) were central (i.e., involved a segmental or larger bronchus), and the remaining 16 lesions (57%) were peripheral. The mean tumor diameter for the 16 peripheral tumors was 14 mm (range, 9-28 mm); the majority (14/16, 88%) had a lobulated contour. Of six peripheral lesions with unenhanced and contrast-enhanced CT nodule enhancement studies, the mean maximal enhancement was 55.2 HU (range, 34-73 HU). Thirteen of the 16 peripheral carcinoid tumors (81%) involved a subsegmental bronchus, with 10 (63%) showing peripheral hyperlucency, bronchiectasis, or atelectasis.
CONCLUSION: In our series, primary pulmonary carcinoid tumors presenting as peripheral SPNs were more common than central endobronchial lesions in contrast to the published literature. The CT features of peripheral carcinoid tumors presenting as SPNs that suggest the diagnosis include lobulated nodules of high attenuation on contrast-enhanced CT; nodules that densely enhance with contrast administration; the presence of calcification; subsegmental airway involvement on thin-section analysis; and nodules associated with distal hyperlucency, bronchiectasis, or atelectasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22021498     DOI: 10.2214/AJR.10.5954

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  18 in total

1.  [Pulmonary carcinoid tumors].

Authors:  H Prosch
Journal:  Radiologe       Date:  2017-05       Impact factor: 0.635

2.  Survival Prognostic Value of Morphological and Metabolic variables in Patients with Stage I and II Non-Small Cell Lung Cancer.

Authors:  L Domachevsky; D Groshar; R Galili; M Saute; H Bernstine
Journal:  Eur Radiol       Date:  2015-05-01       Impact factor: 5.315

3.  Radiogenomic evaluation of lung cancer - Are there imaging characteristics associated with lung adenocarcinomas harboring BRAF mutations?

Authors:  Darragh F Halpenny; Andrew Plodkowski; Gregory Riely; Junting Zheng; Anya Litvak; Chaya Moscowitz; Michelle S Ginsberg
Journal:  Clin Imaging       Date:  2016-11-30       Impact factor: 1.605

4.  Endobronchial carcinoid tumor in a Crohn disease patient treated with a TNFα inhibitor.

Authors:  Carolina Carcano; Eduardo C Oliveira; Felipe Martinez; Jacobo Kirsch
Journal:  Transl Lung Cancer Res       Date:  2013-02

5.  Clinicopathological, Oncogenic, and 18F-FDG PET/CT Features of Primary Pulmonary Carcinoid in Resection Specimens.

Authors:  Yun Chen; Yun Dong; Jingyun Shi; Long Zhao
Journal:  Contrast Media Mol Imaging       Date:  2022-06-15       Impact factor: 3.009

6.  Contribution of 18F-FDG PET/CT in the Differential Diagnosis of Pulmonary Hamartomas and Pulmonary Carcinoids

Authors:  Ebru Tatcı; Özlem Özmen; Ayperi Öztürk; Funda Demirağ
Journal:  Mol Imaging Radionucl Ther       Date:  2021-06-03

7.  Duodeno-colic fistula as a rare presentation of lung cancer - surgical treatment of a stage IV oligometastatic lung disease.

Authors:  Vitor Nunes; Inês Santiago; Rui Marinho; David Pires; Rita Theias; António Gomes; Nuno Pignatelli
Journal:  Int J Surg Case Rep       Date:  2015-07-09

8.  The clinical, radiological, and bronchoscopic findings and outcomes in patients with benign tracheobronchial tumors.

Authors:  Byung Woo Jhun; Kyung-Jong Lee; Kyeongman Jeon; Sang-Won Um; Gee Young Suh; Man Pyo Chung; O Jung Kwon; Hojoong Kim
Journal:  Yonsei Med J       Date:  2014-01       Impact factor: 2.759

9.  Marked 18-Fuorine-Fluorodeoxyglucose (FDG) Avidity of an Intrapulmonary Typical Carcinoid Tumor Manifesting as a Bronchocele in an Asymptomatic Middle-Aged Woman.

Authors:  Camila Saadé-Yordán; Edward McBurney-Henriquez; Ricardo González-Santoni; Carmen Gurrea-Rosas; José Montalvo-Fitzpatrick; José A Maldonado-Vargas
Journal:  Am J Case Rep       Date:  2017-12-28

10.  Peripheral pulmonary carcinoid tumor diagnosed by endobronchial-ultrasound-guided bronchoscopy.

Authors:  Ayaka Tanaka; Hiroaki Akamatsu; Hiroki Kawabata; Hiroyuki Ariyasu; Yasushi Nakamura; Nobuyuki Yamamoto
Journal:  Respirol Case Rep       Date:  2015-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.